losartan has been researched along with Intraocular Pressure in 5 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Intraocular Pressure: The pressure of the fluids in the eye.
Excerpt | Relevance | Reference |
---|---|---|
"The neuroprotective effect of losartan in mouse glaucoma is associated with adaptive changes in the sclera expressed at the optic nerve head." | 7.81 | Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma. ( Berlinicke, CA; Jefferys, JJ; Kim, J; Kimball, EC; Mitchell, KL; Nguyen, C; Nguyen, TD; Oglesby, EN; Pease, ME; Pitha, IF; Quigley, HA; Steinhart, MR; Welsbie, DS, 2015) |
"The neuroprotective effect of losartan in mouse glaucoma is associated with adaptive changes in the sclera expressed at the optic nerve head." | 3.81 | Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma. ( Berlinicke, CA; Jefferys, JJ; Kim, J; Kimball, EC; Mitchell, KL; Nguyen, C; Nguyen, TD; Oglesby, EN; Pease, ME; Pitha, IF; Quigley, HA; Steinhart, MR; Welsbie, DS, 2015) |
"To examine the effects of losartan on scar formation after trabeculectomy and on fibrotic changes of human Tenon's fibroblasts (HTFs)." | 1.46 | Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy. ( Fu, S; Shi, H; Wang, H; Xiao, Y; Xu, K; Ye, W; Zhang, X, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Korneva, A | 1 |
Schaub, J | 1 |
Jefferys, J | 1 |
Kimball, E | 1 |
Pease, ME | 2 |
Nawathe, M | 1 |
Johnson, TV | 1 |
Pitha, I | 1 |
Quigley, H | 1 |
Quigley, HA | 1 |
Pitha, IF | 1 |
Welsbie, DS | 1 |
Nguyen, C | 1 |
Steinhart, MR | 1 |
Nguyen, TD | 1 |
Oglesby, EN | 1 |
Berlinicke, CA | 1 |
Mitchell, KL | 1 |
Kim, J | 1 |
Jefferys, JJ | 1 |
Kimball, EC | 1 |
Shi, H | 1 |
Wang, H | 1 |
Fu, S | 1 |
Xu, K | 1 |
Zhang, X | 1 |
Xiao, Y | 1 |
Ye, W | 1 |
Spicher, T | 1 |
Orgül, S | 1 |
Gugleta, K | 1 |
Teuchner, B | 1 |
Flammer, J | 1 |
Krohn, J | 1 |
Bjune, C | 1 |
1 trial available for losartan and Intraocular Pressure
Article | Year |
---|---|
The effect of losartan potassium on choroidal hemodynamics in healthy subjects.
Topics: Administration, Oral; Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Flow V | 2002 |
4 other studies available for losartan and Intraocular Pressure
Article | Year |
---|---|
A method to quantify regional axonal transport blockade at the optic nerve head after short term intraocular pressure elevation in mice.
Topics: Amyloid beta-Protein Precursor; Animals; Antihypertensive Agents; Axonal Transport; Axons; Disease M | 2020 |
Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma.
Topics: Animals; Disease Models, Animal; Glaucoma; Humans; Intraocular Pressure; Losartan; Mice; Neuroprotec | 2015 |
Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy.
Topics: Actins; Aged; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cell Movement; Ce | 2017 |
Uveal effusion and angle-closure glaucoma in primary pulmonary hypertension.
Topics: Aged; Antihypertensive Agents; Conjunctiva; Corneal Edema; Dilatation, Pathologic; Female; Glaucoma, | 2003 |